tiprankstipranks
Advertisement
Advertisement

PFE Stock Latest News

Pfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27
RatingsPfizer Kept at Hold as Oncology Catalyst Nears, Valuation Keeps Price Target Unchanged at $27
1h ago
PFE
Pfizer Juggles Trial Win, Setback and New Vaccine Bet
PremiumWeekend Updates
Pfizer Juggles Trial Win, Setback and New Vaccine Bet
3d ago
PFE
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
4d ago
AZN
LLY
Pfizer’s Bevacizumab Biosimilar Study in Japan: What Investors Should Watch
PremiumCompany Announcements
Pfizer’s Bevacizumab Biosimilar Study in Japan: What Investors Should Watch
4d ago
PFE
Pfizer Advances New Migraine Tablet Formulation With Phase 1 Bioequivalence Study
PremiumCompany Announcements
Pfizer Advances New Migraine Tablet Formulation With Phase 1 Bioequivalence Study
4d ago
PFE
Pfizer Tests New Tafamidis Tablet Forms in Phase 1 Bioequivalence Study
PremiumCompany AnnouncementsPfizer Tests New Tafamidis Tablet Forms in Phase 1 Bioequivalence Study
4d ago
PFE
Pfizer’s Phase 3 Lyme Vaccine Trial Nears the Finish Line: What Investors Should Know
Premium
Company Announcements
Pfizer’s Phase 3 Lyme Vaccine Trial Nears the Finish Line: What Investors Should Know
4d ago
PFE
Pfizer Terminates Early KRAS Cancer Trial: What It Means for PFE Investors
Premium
Company Announcements
Pfizer Terminates Early KRAS Cancer Trial: What It Means for PFE Investors
4d ago
PFE
Pfizer: Hold Rating Reiterated as Competitive Pressures Offset Pipeline Upside; $26 Price Target Maintained
PremiumRatings
Pfizer: Hold Rating Reiterated as Competitive Pressures Offset Pipeline Upside; $26 Price Target Maintained
5d ago
PFE
Pfizer Maintained at Buy on Vaccine Franchise Strength and Pipeline Potential; $34 Price Target Reaffirmed
PremiumRatings
Pfizer Maintained at Buy on Vaccine Franchise Strength and Pipeline Potential; $34 Price Target Reaffirmed
6d ago
PFE
Moderately bullish activity in Pfizer with shares up 0.41%
PremiumThe Fly
Moderately bullish activity in Pfizer with shares up 0.41%
6d ago
PFE
Pfizer announces pneumococcal conjugate vaccine candidate data
PremiumThe Fly
Pfizer announces pneumococcal conjugate vaccine candidate data
7d ago
PFE
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial
PremiumCompany AnnouncementsPfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial
7d ago
PFE
Trump Trade: Trump announces expansion of TrumpRx.gov
Premium
The Fly
Trump Trade: Trump announces expansion of TrumpRx.gov
7d ago
AZN
BMY
PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’
Premium
Market News
PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’
8d ago
AZN
LLY
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
PremiumThe Fly
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
8d ago
AZN
BMY
Pfizer (PFE) Juggles New Trials, Site Shifts and Mixed Wall Street Bets
PremiumWeekend Updates
Pfizer (PFE) Juggles New Trials, Site Shifts and Mixed Wall Street Bets
10d ago
PFE
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
PremiumThe Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
11d ago
AZN
BMY
Pfizer Refines PF-07799933 Dosing in New Phase 1 Food-Effect Study
PremiumCompany Announcements
Pfizer Refines PF-07799933 Dosing in New Phase 1 Food-Effect Study
11d ago
PFE
Pfizer’s New Korea Migraine Study Puts NURTEC ODT Under Real‑World Spotlight
PremiumCompany AnnouncementsPfizer’s New Korea Migraine Study Puts NURTEC ODT Under Real‑World Spotlight
11d ago
PFE
Pfizer price target raised to $26 from $25 at Wolfe Research
Premium
The Fly
Pfizer price target raised to $26 from $25 at Wolfe Research
12d ago
PFE
Pfizer’s New Japan RSV Vaccine Trial Signals Ongoing Expansion for PFE
Premium
Company Announcements
Pfizer’s New Japan RSV Vaccine Trial Signals Ongoing Expansion for PFE
12d ago
PFE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >